Pfizer (PFE) Q4 Earnings Top, Revenues Miss on COVID Sales Slump

Pfizer (PFE) reported fourth-quarter 2023 adjusted earnings per share of 10 cents in contrast to the Zacks Consensus Estimate of a loss of 19 cents per share. In the year-ago quarter, the company had recorded earnings of $1.41 per share.Revenues came in at$14.25 billion, down 41% from the year-ago quarter on a reported basis, reflecting an operational decline of 42% but a currency benefit of 1%. Total revenues missed the Zacks Consensus Estimate of $14.37 billion.The revenue decline, as expected, was due t ...